Integrating Genetics and the Plasma Proteome to Predict the Risk of Type 2 Diabetes

[1] Harris MI(1992)Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis Diabetes Care 15 815-819

[2] Klein R(2009)Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study Lancet. 373 2215-2221

[3] Welborn TA(2012)How much does screening bring forward the diagnosis of type 2 diabetes and reduce complications? Twelve year follow-up of the Ely cohort Diabetologia. 55 1651-1659

[4] Knuiman MW(1998)United Kingdom prospective diabetes study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors Arch Ophthalmol 116 297-303

[5] Tabak AG(2018)Management of hyperglycemia in type 2 diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care 41 2669-2701

[6] Jokela M(2020)Classification and diagnosis of diabetes: standards of medical care in diabetes-2020 Diabetes Care 43 S14-S31

[7] Akbaraly TN(2012)Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study BMJ. 345 e5900-2182

[8] Brunner EJ(2014)Polygenic type 2 diabetes prediction at the limit of common variant detection Diabetes. 63 2172-1224

[9] Kivimaki M(2018)Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations Nat Genet 50 1219-2474

[10] Witte DR(2018)Genomic insights into the causes of type 2 diabetes Lancet. 391 2463-34

[1] Harris MI(1992)Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis Diabetes Care 15 815-819

[2] Klein R(2009)Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study Lancet. 373 2215-2221

[3] Welborn TA(2012)How much does screening bring forward the diagnosis of type 2 diabetes and reduce complications? Twelve year follow-up of the Ely cohort Diabetologia. 55 1651-1659

[4] Knuiman MW(1998)United Kingdom prospective diabetes study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors Arch Ophthalmol 116 297-303

[5] Tabak AG(2018)Management of hyperglycemia in type 2 diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care 41 2669-2701

[6] Jokela M(2020)Classification and diagnosis of diabetes: standards of medical care in diabetes-2020 Diabetes Care 43 S14-S31

[7] Akbaraly TN(2012)Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study BMJ. 345 e5900-2182

[8] Brunner EJ(2014)Polygenic type 2 diabetes prediction at the limit of common variant detection Diabetes. 63 2172-1224

[9] Kivimaki M(2018)Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations Nat Genet 50 1219-2474

[10] Witte DR(2018)Genomic insights into the causes of type 2 diabetes Lancet. 391 2463-34